Page last updated: 2024-10-30

meclizine and Allergic Reaction

meclizine has been researched along with Allergic Reaction in 1 studies

Meclizine: A histamine H1 antagonist used in the treatment of motion sickness, vertigo, and nausea during pregnancy and radiation sickness.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Jang, EH2
Bae, HD2
Jeon, Y2
Shin, DH2
Kang, S2
Lee, K2

Other Studies

1 other study available for meclizine and Allergic Reaction

ArticleYear
Meclizine, a piperazine-derivative antihistamine, binds to dimerized translationally controlled tumor protein and attenuates allergic reactions in a mouse model.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2023, Volume: 157

    Topics: Animals; Biomarkers, Tumor; Disease Models, Animal; Histamine Antagonists; Hypersensitivity; Meclizi

2023
Meclizine, a piperazine-derivative antihistamine, binds to dimerized translationally controlled tumor protein and attenuates allergic reactions in a mouse model.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2023, Volume: 157

    Topics: Animals; Biomarkers, Tumor; Disease Models, Animal; Histamine Antagonists; Hypersensitivity; Meclizi

2023
Meclizine, a piperazine-derivative antihistamine, binds to dimerized translationally controlled tumor protein and attenuates allergic reactions in a mouse model.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2023, Volume: 157

    Topics: Animals; Biomarkers, Tumor; Disease Models, Animal; Histamine Antagonists; Hypersensitivity; Meclizi

2023
Meclizine, a piperazine-derivative antihistamine, binds to dimerized translationally controlled tumor protein and attenuates allergic reactions in a mouse model.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2023, Volume: 157

    Topics: Animals; Biomarkers, Tumor; Disease Models, Animal; Histamine Antagonists; Hypersensitivity; Meclizi

2023